Chemours Valuation
| 2CU Stock | EUR 14.77 0.87 6.26% |
At this time, the firm appears to be overvalued. Chemours shows a prevailing Real Value of €13.5 per share. The current price of the firm is €14.77. Our model approximates the value of Chemours from analyzing the firm fundamentals such as profit margin of (0.05) %, and Return On Equity of -0.67 as well as examining its technical indicators and probability of bankruptcy.
Price Book 8.2575 | Enterprise Value 5.5 B | Enterprise Value Ebitda 15.3817 | Price Sales 0.3792 | Forward PE 9.4877 |
Overvalued
Today
Please note that Chemours' price fluctuation is not too volatile at this time. Calculation of the real value of Chemours is based on 3 months time horizon. Increasing Chemours' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Chemours stock is determined by what a typical buyer is willing to pay for full or partial control of Chemours Co. Since Chemours is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemours Stock. However, Chemours' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.77 | Real 13.5 | Hype 15.15 | Naive 13.61 |
The real value of Chemours Stock, also known as its intrinsic value, is the underlying worth of Chemours Company, which is reflected in its stock price. It is based on Chemours' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Chemours' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Chemours Co helps investors to forecast how Chemours stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemours more accurately as focusing exclusively on Chemours' fundamentals will not take into account other important factors: Chemours Cash |
|
Chemours Total Value Analysis
Chemours Co is presently estimated to have takeover price of 5.49 B with market capitalization of 2.21 B, debt of 54 M, and cash on hands of 630 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Chemours fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.49 B | 2.21 B | 54 M | 630 M |
Chemours Investor Information
About 95.0% of the company shares are owned by institutions such as pension funds. The company has Price/Earnings To Growth (PEG) ratio of 1.7. Chemours recorded a loss per share of 1.8. The entity last dividend was issued on the 14th of November 2025. Based on the key indicators related to Chemours' liquidity, profitability, solvency, and operating efficiency, Chemours Co is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.Chemours Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemours has an asset utilization ratio of 76.94 percent. This implies that the Company is making €0.77 for each dollar of assets. An increasing asset utilization means that Chemours Co is more efficient with each dollar of assets it utilizes for everyday operations.Chemours Profitability Analysis
Based on Chemours' profitability indicators, Chemours Co may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Chemours' ability to earn profits and add value for shareholders.Net Income | First Reported 2017-12-31 | Previous Quarter -381 M | Current Value 60 M | Quarterly Volatility 171.8 M |
For Chemours profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chemours to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chemours utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chemours's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chemours over time as well as its relative position and ranking within its peers.
Chemours Earnings per Share Projection vs Actual
By analyzing Chemours' earnings estimates, investors can diagnose different trends across Chemours' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Chemours Co is based on EPS before non-recurring items and includes expenses related to employee stock options.Chemours Ownership Allocation
Chemours holds a total of 149.89 Million outstanding shares. The majority of Chemours Co outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of Chemours Co as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chemours Profitability Analysis
The company reported the revenue of 5.78 B. Net Income was 86 M with profit before overhead, payroll, taxes, and interest of 1.02 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Chemours' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Chemours and how it compares across the competition.
About Chemours Valuation
The stock valuation mechanism determines Chemours' current worth on a weekly basis. Our valuation model uses a comparative analysis of Chemours. We calculate exposure to Chemours's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chemours's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.3 B | 1.5 B |
Chemours Quarterly Retained Earnings |
|
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |